How Ozempic is upending the weight loss industry
In 1983, Jenny Craig and her husband Sidney opened nine weight loss centres across Melbourne. Over the next forty years millions of overweight people paid to weigh in, pick up meals and slim down and the business grew to 700 stores in four countries.
But in June, the Australian business went into administration. No one wanted to buy it. But there was a buyer for its mailing list: a four-year-old start up called Eucalyptus that sell the buzzy weight-loss drug Ozempic.
Listen below or stream The Fin on Apple, Spotify or wherever you get your podcasts.
This week in The Fin podcast, technology writer Nick Bonyhady and health editor Jill Margo on how Ozempic has upended the weight-loss industry, which companies are trying to make money from it and whether the health risks threaten to derail its meteoric rise.
Explore the big issues in business, markets and politics with the journalists who know the inside story. New episodes of The Fin are published every Thursday.
Read more on afr.com
